Testing a drug to reduce brain swelling after bleeding
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a drug given directly into the brain's fluid can reduce the need for a permanent shunt after a type of brain bleed. It may help prevent long-term complications from swelling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a brain bleed (subarachnoid hemorrhage) and need a temporary drain (EVD) to relieve pressure
- You can start treatment within about 24 hours of the drain being placed
- You are not pregnant
- You do not have a pre-existing shunt (VP shunt) or a weakened immune system
- You are expected to continue life-sustaining treatment for at least 24 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if sirolimus, a medicine that may help reduce abnormal blood vessels, can prevent another brain bleed in people who recently had a bleed from a brainstem cavernoma. You would receive either sirolimus or a placebo to see if it works.
This trial studies whether an add-on, minimally invasive procedure works better than standard care for a specific brain blood-vessel problem (CSH) that is larger than 10 mm. It may help reduce symptoms or prevent worsening, if you meet the size and location requirements.
This trial tests a new drug called HRS8179 to reduce severe brain swelling after a large stroke. If you have a major stroke on one side of the brain and can start treatment within 10 hours, this study may help prevent dangerous pressure buildup.
This study tests whether giving a combination of blood-pressure-lowering medicines early after a brain bleed can reduce swelling and improve recovery. It aims to start treatment within 3 days of the bleed to see if it helps limit brain damage.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This trial studies a device that delivers a special “embolic” material (often described as glue) to treat a type of abnormal connection in the brain’s blood vessels (dAVF). It may help by blocking the leaking or risky blood flow, and it will be compared against how doctors handle eligible cases with other embolic materials.
Hear when a new Post-hemorrhagic Hydrocephalus (PHH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.